Cancer mortality in IBM Endicott plant workers, 1969–2001: an update on a NY production plant
2008

Cancer Mortality in IBM Endicott Plant Workers

Sample size: 360 publication Evidence: moderate

Author Information

Author(s): Richard W Clapp, Kate Hoffman

Primary Institution: Boston University School of Public Health

Hypothesis

Is there an increased risk of cancer mortality among workers at the IBM plant in Endicott, NY?

Conclusion

The study found significantly increased mortality from melanoma and lymphoma among male workers at the IBM Endicott plant.

Supporting Evidence

  • Significantly increased mortality due to melanoma was observed with a PCMR of 367.
  • Significantly increased mortality due to lymphoma was observed with a PCMR of 220.
  • Modestly increased mortality due to kidney cancer and brain cancer was also noted.
  • Breast cancer showed a modest increase in mortality among female workers.

Takeaway

This study looked at workers from an IBM plant and found that many of them died from certain types of cancer more than expected.

Methodology

The study used mortality and work history files to conduct proportional cancer mortality analysis comparing Endicott workers to state data.

Potential Biases

Potential bias due to the small sample size and reliance on historical data.

Limitations

The analysis is based on a small number of deaths and does not include those not eligible for the Corporate Mortality File.

Participant Demographics

Workers from the IBM Endicott plant, with a significant percentage potentially exposed to carcinogens.

Statistical Information

Confidence Interval

95% CI: 119, 856

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1476-069X-7-13

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication